# EDGAR Filing Document

**Accession Number:** 0000019617
**File Stem:** 0001225208-23-000684
**Filing Date:** 2023-1
**Character Count:** 8688
**Document Hash:** bf1b53c8010e73b769504e9a7d88d3db
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001225208-23-000684.hdr.sgml**: 20230117

**ACCESSION NUMBER**: 0001225208-23-000684

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20230113

**FILED AS OF DATE**: 20230117

**DATE AS OF CHANGE**: 20230117

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Korablina Elena A
- **CENTRAL INDEX KEY:** 0001848100

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-05805
- **FILM NUMBER:** 23532624

**MAIL ADDRESS:**
- **STREET 1:** 383 MADISON AVENUE
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10179-0001
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** JPMORGAN CHASE & CO
- **CENTRAL INDEX KEY:** 0000019617
- **STANDARD INDUSTRIAL CLASSIFICATION:** NATIONAL COMMERCIAL BANKS [6021]
- **IRS NUMBER:** 132624428
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 383 MADISON AVENUE
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10017
- **BUSINESS PHONE:** 2122706000

**MAIL ADDRESS:**
- **STREET 1:** 383 MADISON AVENUE
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10017

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** J P MORGAN CHASE & CO
- **DATE OF NAME CHANGE:** 20010102

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** CHASE MANHATTAN CORP /DE/
- **DATE OF NAME CHANGE:** 19960402

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** CHEMICAL BANKING CORP
- **DATE OF NAME CHANGE:** 19920703

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Korablina Elena A<br><sub>(Last) (First) (Middle)</sub><br>383 MADISON AVENUE<br><sub>(Street)</sub><br>NEW YORK, NY 10179-0001<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2023-01-13 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [ ] 10% Owner<br>[X] Officer (give title below) [ ] Other (specify below)<br>_Corporate Controller_ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>JPMORGAN CHASE & CO [ JPM ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Common Stock | 2023-01-13 |  | M |  | 2940 | A | 0<sup>(1)</sup> | 22658 | D |  |
| Common Stock | 2023-01-13 |  | M |  | 2746 | A | 0<sup>(1)</sup> | 25404 | D |  |
| Common Stock | 2023-01-13 |  | M |  | 1630 | A | 0<sup>(1)</sup> | 27034 | D |  |
| Common Stock | 2023-01-13 |  | M |  | 1262 | A | 0<sup>(1)</sup> | 28296 | D |  |
| Common Stock | 2023-01-13 |  | F |  | 4382 | D | $139.1450 | 23914 | D |  |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| Restricted Stock Units | <sup>(1)</sup> | 2023-01-13 |  | M |  |  | 1630 | <sup>(2)</sup> | 2023-01-13 | Common Stock | 1630 | $0 | 0 | D |  |
| Restricted Stock Units | <sup>(1)</sup> | 2023-01-13 |  | M |  |  | 2746 | <sup>(3)</sup> | 2024-01-13 | Common Stock | 2746 | $0 | 2747 | D |  |
| Restricted Stock Units | <sup>(1)</sup> | 2023-01-13 |  | M |  |  | 1262 | <sup>(4)</sup> | 2025-01-13 | Common Stock | 1262 | $0 | 3864 | D |  |
| Restricted Stock Units | <sup>(1)</sup> | 2023-01-13 |  | M |  |  | 2940 | <sup>(5)</sup> | 2026-01-13 | Common Stock | 2940 | $0 | 8822 | D |  |

---

### Footnotes:

(1) Each restricted stock unit represents a contingent right to receive one share of JPMC common stock.

(2) Restricted stock units vest 1/3 on each of the following dates: January 13, 2021, January 13, 2022, and January 13, 2023. As Identified Staff at the time of grant, shares resulting from vesting must be held for 12 months from vesting date.

(3) Restricted stock units grant of 3,417 shares will vest as follows: 1,139 shares on January 13, 2022, 1,139 shares on January 13, 2023, and 1,139 shares on January 13, 2024. The shares resulting from vesting are subject to a hold for 6 months from vesting date. Restricted stock units grant of 4,822 shares will vest as follows: 1,607 shares on January 13, 2022, 1,607 shares on January 13, 2023, and 1,608 shares on January 13, 2024. The shares resulting from vesting are subject to a hold for 12 months from vesting date.

(4) Restricted stock units grant of 6,310 shares vest as follows: 1,262 shares on January 13, 2021, 1,262 shares on January 13, 2022, 1,262 shares on January 13, 2023, 1,262 shares on January 13, 2024, and 1,262 shares on January 13, 2025. As Identified Staff at the time of grant, shares resulting from vesting must be held for 12 months from vesting date. Restricted stock units grant of 1,340 shares vest as follows: 670 shares on January 13, 2024, and 670 shares on January 13, 2025.

(5) Restricted stock units grant of 5,600 shares vests as follows: 1,400 shares on January 13, 2023, 1,400 shares on January 13, 2024, 1,400 shares on January 13, 2025, and 1,400 shares on January 13, 2026. As Identified Staff at the time of grant, the shares resulting from vesting must be held for 12 months from vesting date. Restricted stock units grant of 7,702 shares vests as follows: 1,540 shares on January 13, 2022, 1,540 shares on January 13, 2023, 1,540 shares on January 13, 2024, 1,541 shares on
January 13, 2025, and 1,541 shares on January 13, 2026. As Identified Staff for a portion of year to which the grant relates, the shares resulting from vesting must be held for 12 months from vesting date.

**Signature:** /s/ Holly Youngwood under POA  
**Date:** 2023-01-17

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**